CharlesMFogartyMD

Critical Care Medicine

Medical Director, Spartanburg Medical Research Partner, Lung & Chest Medical Associates Medical Director, Spartanburg Community College Respiratory Therapy

Join to view full profile

Dr. Fogarty is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fogarty's full profile

Already have an account?

Office
2030 N Church Place
Spartanburg, SC 29303
Phone+1 864-558-2685

Fax+1 864-585-0999

Education & Training

University of Pennsylvania Health SystemFellowship, Pulmonary Disease and Critical Care Medicine, 1975 - 1977
University of Rochester Medical CenterResidency, Internal Medicine, 1973 - 1975
University of Rochester Medical CenterInternship, Internal Medicine, 1970 - 1971
University of Rochester School of Medicine and DentistryClass of 1970

Certifications & Licensure

NY State Medical License 1971 - Present
SC State Medical License 1978 - 2025
PA State Medical License 1975 - 1978
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects Start of enrollment: 2014 Mar 01
Completed
Phase 1
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2

Publications & Presentations

PubMed

1 citations
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, plac...
Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira L Lugogo, Christopher E Brightling
The Lancet. Respiratory Medicine. 2025-03-01
3 citations
A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).
Susanna K Tan, Deborah Cebrik, David Plotnik, Maria L Agostini, Keith Boundy
Clinical Infectious Diseases. 2024-10-15
53 citations
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F (RSVPreF3) Candidate Vaccine in Older Adults: Phase 1/2 Randomized Clinical Trial.
Isabel Leroux-Roels, Matthew G Davis, Katie Steenackers, Brandon Essink, Corinne Vandermeulen
The Journal of Infectious Diseases. 2023-03-28

Journal Articles

Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults
Charles Fogarty, MD, JAMA Network Open
The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults: An Open Phase III Trial
Myron J Levin, David Butuk, Kenneth E Schmader, Charles Fogarty, Paul Hartley, Max Nevarez, Nicola P Klein, Kari Uusinarkaus, The Journals of Gerontology